The Trump administration has threatened to withhold critical HIV treatment funding from Zambia unless the African nation grants American companies expanded access to its mineral resources, setting a precedent that has alarmed the global health community and raised questions about the future of humanitarian aid.
The extraordinary ultimatum, first reported by The New York Times, involves the President's Emergency Plan for AIDS Relief (PEPFAR), which provides antiretroviral therapy to more than 1.2 million Zambians living with HIV—representing roughly 80% of all treatment in the country.
US officials have explicitly linked continued funding to Zambian cooperation on mining concessions for copper, cobalt, and rare earth elements critical to electric vehicle batteries and renewable energy technology. The minerals in question are essential to Washington's strategy to reduce dependence on Chinese-dominated supply chains.
Dr. John Nkengasong, former director of the Africa Centres for Disease Control and Prevention, called the policy "unconscionable" and warned it could "undermine decades of progress in global health cooperation." He noted that interrupting HIV treatment not only harms individual patients but can accelerate the development of drug-resistant strains of the virus.
Zambia, a landlocked nation of 20 million people in southern Africa, has one of the highest HIV prevalence rates in the world, with approximately 11% of adults living with the virus. PEPFAR funding, established during the George W. Bush administration in 2003, has been credited with saving millions of lives across Africa and represents one of the most successful American foreign aid programs in history.
The Zambian government has not publicly responded to the ultimatum, but sources within the Ministry of Health told the Times that officials are "deeply concerned" about the humanitarian implications. Zambia lacks the financial resources to replace US funding if it is withdrawn.
The policy represents a dramatic departure from bipartisan American support for PEPFAR, which has historically been shielded from political considerations. Previous administrations of both parties maintained that health aid should not be conditioned on unrelated policy objectives.
Professor Lawrence Gostin, director of the O'Neill Institute for National and Global Health Law at Georgetown University, said the policy "sets a dangerous precedent for the commodification of humanitarian assistance." He added that "if health aid becomes transactional, we can expect other nations to follow suit, potentially unraveling the entire architecture of global health cooperation."
The timing of the ultimatum is particularly significant as China has dramatically expanded its economic presence in Zambia, becoming the country's largest trading partner and a major investor in mining operations. Beijing has also increased health assistance to African nations, positioning itself as a more reliable partner than the West.
Zambia sits atop some of the world's richest deposits of minerals essential to the green energy transition. The country produces roughly 800,000 metric tons of copper annually and holds significant cobalt reserves. Chinese firms currently control substantial portions of Zambian mining operations, a situation Washington seeks to reverse.
The Global Fund to Fight AIDS, Tuberculosis and Malaria issued a carefully worded statement emphasizing that "health aid should be based solely on epidemiological need and public health priorities, not geopolitical considerations." The organization did not directly criticize the US policy but noted that "predictable, sustained funding is essential to maintaining treatment programs."
Several US public health organizations, including AMFAR and the Elizabeth Glaser Pediatric AIDS Foundation, have expressed opposition to conditioning health aid on mining access. More than 200 global health experts signed an open letter calling the policy "a violation of medical ethics and international norms."
The African Union has scheduled an emergency session to address the issue, with several member states expected to condemn the US approach. South Africa's foreign minister described the policy as "health colonialism" and called for collective African resistance to such pressure.
If implemented, the policy could have devastating consequences. Interrupting antiretroviral therapy leads to rapid viral rebound, increased transmission risk, and higher mortality rates. Health experts warn that even the threat of funding cuts could cause panic among patients and destabilize treatment programs.
To understand today's headlines, we must look at yesterday's decisions. The weaponization of health aid represents a fundamental shift in how the United States conducts foreign policy—one that prioritizes resource extraction over humanitarian principles and may ultimately damage American credibility in the developing world for generations to come.
